Sharps Technology Inc(STSS)
USD --+0.00%
Reward42Moderate
Risk93High
📊75%Data
STSS
+0.0 · +0.00%
USD · NASDAQ
Sharps Technology Inc | Healthcare
Speculative Momentum
Market Cap:90.61M
ℹ️
Reward Rating
42
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
93
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on STSS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $22.00.

What is Sharps Technology Inc?

, a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry.

STSS · Verdict

Moderate reward · high risk

STSS has limited near-term tailwinds — cash flow and volatility weigh on the model output.

Based on 88% data coverage

STSS · Verdict

What’s working & what to watch

Watchouts 4

  • Cash flow5/100

    Weak vs peers

  • Volatility5/100

    Weak vs peers

  • Balance sheet6/100

    Current ratio 0.61

  • Profitability10/100

    -7% return on equity

Model-based scoring. For information only — not financial advice.

What is Sharps Technology Inc?

, a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 90.61M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (42)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap90.61M
P/E RatioN/A
Dividend YieldN/A
52 Week High132
52 Week Low1.415
Last AnnualDecember
IPO Date4/14/2022
IncorporatedUSA
Shares Outstanding28M
No. of Employees55
IndustryMedical Instruments & Supplies
ExchangeNASDAQ
Beta2.128
CurrencyUSD